Camp Lejeune cancer lawsuit

A Medical Diagnosis Of A Specific Type Of Cancer Is Key To Camp Lejeune Justice Act Compensation

Others may have to file a lawsuit to receive compensation for their water-related injuries

Monday, March 11, 2024 - The type of cancer that a US marine develops is critically important when filing a Camp Lejeune Justice Act claim. It is assumed that if the cancer is not one of a dozen or so on the list the claim will be denied or ignored. If the Navy fails to respond to one's claim, the person or their surviving loved ones may file a Camp Lejeune Justice Act lawsuit in a court in the Eastern District of North Carolina. The following types of cancer are presumed to have been caused by drinking Camp Lejeune tap water according to the Veterans Administration (VA). The VA writes, " VA has established a presumptive service connection for Veterans, Reservists, and National Guard members exposed to contaminants in the water supply at Camp Lejeune from August 1, 1953, through December 31, 1987 who later developed one of the following eight diseases: Adult leukemia, Aplastic anemia and other myelodysplastic syndromes, Bladder cancer, Kidney cancer, Liver cancer, Multiple myeloma, Non-Hodgkin's lymphoma and Parkinson's disease. Presently, these conditions are the only ones for which there is sufficient scientific and medical evidence to support the creation of presumptions; however, VA will continue to review relevant information as it becomes available." A study by the CDC that was released recently added more common types of cancer to those that may have been caused by contaminated Camp Lejeune water, however, there is no indication that the Navy would be willing to automatically add them to the presumptive cancer list.

CNN gave more details about the Camp Lejeune water contamination predicament. From 1953 until 1985, drinking water at Camp Lejeune was highly contaminated with several industrial chemicals known to cause cancer, such as vinyl chloride, benzene, trichloroethylene, or TCE. Thousands of Marines and Navy personnel, as well as civilian workers at the facility, unintentionally ingested the chemicals through drinking water, breathed in shower steam, or even just washed their hands. When the CDC analyzed the odds of various cancers and Parkinson's disease among veterans of Camp Lejune and Camp Pendleton in California, it discovered that those in North Carolina had a somewhat greater risk. So.me experts believe that more than one million US marines and civilian employees and with their families may have been exposed to water contamination

The investigation found multiple other cancers that had not previously been linked to the contamination there, in addition to male breast cancer. These included all myeloid cancers, including polycythemia vera, a blood cancer; cancers of the esophagus, voice box, thyroid, and soft tissues; marginal B-cell lymphoma; and certain lung cancers. Myelodysplastic and myeloproliferative syndromes are a group of disorders caused by blood cells that are not formed properly or don't work right. According to CNN, the study discovered that military people who served in Camp Lejeune had a minimum 20% higher chance of acquiring such cancers when compared to those at Camp Pendleton in California.

Information provided by CampLejeuneJusticeActClaim.com, a website devoted to providing news about Camp Lejeune Justice Act Claim, including a free no-cost, no-obligation Camp Lejeune Justice Act Claim.

More Recent Camp Lejeune Water Lawsuit News:

View all Camp Lejeune Justice Act Claim News

No-Cost, No-Obligation Claim Review for Persons or Families of Persons Who Developed Cancer After Spending 30 Days or More at Camp Lejeune between 1953 and 1988

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.


Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.